When was the Osaka International Cancer Institute founded, and what is its primary specialization?

The institute was founded in 1959 and is a specialized medical institution dedicated exclusively to cancer treatment and research.

Who is Dr. Kei Kunimasa and what role does he hold in the research project mentioned?

Dr. Kei Kunimasa serves as the Deputy Director of Respiratory Medicine and leads the research project selected for AMED’s FY2026 Innovative Cancer Medical Practical Application Research Project.

How does the Osaka International Cancer Institute describe its philosophy toward patient care and medical development?

The institute’s philosophy emphasizes providing and developing advanced cancer medical care from the patient’s perspective, prioritizing high-quality treatment, innovative research, and human resource development.

In what capacity does the Osaka International Cancer Institute serve the Osaka region, according to the article?

The institute acts as a prefectural designated cancer care hospital, supporting cancer medical care throughout Osaka and contributing broadly to society by maintaining close, patient‑family‑centered clinical practice.

AI News NQ Analysis

Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'

NQ Score 65/100

N1 Content Completeness 5

Key facts

Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project'
The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).
Source: PR TIMES
Date: Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)

Direct answer

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

Citation: Research Project by Dr. Kei Kunimasa, Deputy Director of Respiratory Medicine, Selected for AMED's FY2026 'Innovative Cancer Medical Practical Application Research Project' (Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Apr 13 2026 14:00:01 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

The research project proposed by Dr. Kei Kunimasa of the Osaka International Cancer Institute has been selected for the FY2026 'Innovative Cancer Medical Practical Application Research Project' by the Japan Agency for Medical Research and Development (AMED).

AI Analysis

Frequently Asked Questions

Q: When was the Osaka International Cancer Institute founded, and what is its primary specialization?: A: The institute was founded in 1959 and is a specialized medical institution dedicated exclusively to cancer treatment and research.
Q: Who is Dr. Kei Kunimasa and what role does he hold in the research project mentioned?: A: Dr. Kei Kunimasa serves as the Deputy Director of Respiratory Medicine and leads the research project selected for AMED’s FY2026 Innovative Cancer Medical Practical Application Research Project.
Q: What specific AMED program selected the research project led by Dr. Kei Kunimasa, and in which fiscal year?: A: The research project was selected by AMED under its FY2026 Innovative Cancer Medical Practical Application Research Project program, aiming to translate advanced cancer therapies into clinical practice.
Q: How does the Osaka International Cancer Institute describe its philosophy toward patient care and medical development?: A: The institute’s philosophy emphasizes providing and developing advanced cancer medical care from the patient’s perspective, prioritizing high-quality treatment, innovative research, and human resource development.
Q: In what capacity does the Osaka International Cancer Institute serve the Osaka region, according to the article?: A: The institute acts as a prefectural designated cancer care hospital, supporting cancer medical care throughout Osaka and contributing broadly to society by maintaining close, patient‑family‑centered clinical practice.